Beta Bionics (BBNX) Equity Ratio (2023 - 2026)

Beta Bionics' Equity Ratio history runs 4 years deep, the most recent figure standing at 0.89 for Q1 2026.

• In Q1 2026, Equity Ratio fell 4.0% year-over-year to 0.89; the TTM figure through Mar 2026 stood at 0.89 (down 4.0% YoY), while the FY2025 annual figure was 0.87, up 153.36% from the prior year.
• Equity Ratio came in at 0.89 for Q1 2026 at Beta Bionics, up from 0.87 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.93 in Q1 2025 to a low of 1.85 in Q4 2023.
• A 4-year average of 0.15 and a median of 0.89 in 2026 frame the typical range for Equity Ratio.
• Across the five-year window, Equity Ratio surged 153.36% in 2025 and decreased 4.0% in 2026, its largest moves.
• Beta Bionics' Equity Ratio stood at 1.85 in 2023, then grew by 11.17% to 1.64 in 2024, then soared by 153.36% to 0.87 in 2025, then advanced by 1.85% to 0.89 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.89, 0.87, and 0.89 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison